Literature DB >> 30880757

Investigation of apoptotic effect of juglone on CCL-228-SW 480 colon cancer cell line.

Dilek Bayram1, Meltem Özgöçmen1, Ilkay Armagan1, Murat Sevimli1, Gülçin Yavuz Türel2, Nurgül Şenol3.   

Abstract

BACKGROUND: Colon cancer is a major cause of morbidity and mortality in the world. Juglone is a natural compound which has been isolated from Juglans mandshurica Maxim, and it has various pharmacological effects such as antiviral, antibacterial, and anticancer. In our study, we aimed to investigate the effect of juglone on CCL-228-SW 480 colon carcinoma cell line in monolayer and spheroid culture medium.
MATERIALS AND METHODS: The CCL-228-SW 480 cell lines were cultured in both monolayer and spheroid cultures. Cells were treated with juglone at 24, 48, and 72 h of incubation. ID50 inhibition was determined on the dose for juglone and after it was found 20 μM was applied to the cells to examine the effect of juglone on CCL-228-SW 480 colon carcinoma cell line. After Juglone was applied the BrdU marking index, Transferase dUTP Nick ends Labeling (TUNEL) assay, active caspase-3 assay, apoptosis-inducing factor (AIF) assay were determined by immunohistochemistry in both the monolayer and spheroid cultures.
RESULTS: The control group had a healthy pattern of S-phase fraction, and many of the CCL-228-SW 480 cells nuclei were observed to be positive for BrdU. Terminal Deoxynucleotidyl TUNEL-positive cells, active Caspase-3, and AIF were detected after treatment with juglone in both the monolayer and spheroid cultures.
CONCLUSIONS: The dead cell count was higher in the CCL-228-SW 480 cell lines with juglone applied than in the controls. Juglone significantly inhibits the proliferation and induces the apoptosis of CCL-228-SW 480 cells in vitro.

Entities:  

Keywords:  Apoptosis; CCL-228-SW 480 cell line; colon cancer; in vitro; juglone

Mesh:

Substances:

Year:  2019        PMID: 30880757     DOI: 10.4103/jcrt.JCRT_880_17

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  3 in total

1.  The Anti-Glioma Effect of Juglone Derivatives through ROS Generation.

Authors:  Jinsen Zhang; Minjie Fu; Jinfeng Wu; Fengfeng Fan; Xin Zhang; Chunjie Li; Hui Yang; Yonghe Wu; Yiming Yin; Wei Hua
Journal:  Front Pharmacol       Date:  2022-06-14       Impact factor: 5.988

2.  Cytotoxicity of juglone and thymoquinone against pancreatic cancer cells.

Authors:  Namrata Karki; Sita Aggarwal; Roger A Laine; Frank Greenway; Jack N Losso
Journal:  Chem Biol Interact       Date:  2020-06-28       Impact factor: 5.168

Review 3.  Juglans mandshurica Maxim.: A Review of Its Traditional Usages, Phytochemical Constituents, and Pharmacological Properties.

Authors:  Fei Luan; Ziyan Wang; Yan Yang; Yafei Ji; Haizhen Lv; Keqing Han; Daoheng Liu; Xiaofei Shang; Xirui He; Nan Zeng
Journal:  Front Pharmacol       Date:  2021-01-21       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.